Italian Society of Infectious and Tropical Diseases (SIMIT), Prato, Italy; IRCCS Istituto Auxologico Italiano, San Luca Hospital, Milan, Italy.
IRCCS Fondazione Santa Lucia, Rome, Italy.
Int J Antimicrob Agents. 2022 Jun;59(6):106594. doi: 10.1016/j.ijantimicag.2022.106594. Epub 2022 Apr 25.
Carbapenemase-producing Enterobacterales (CPE) represent a serious threat to public health worldwide. Elderly patients are at increased risk of colonisation/infection with CPE. This study aimed to evaluate the persistence of CPE colonisation and the genotypic characteristics of persistent strains in elderly people discharged from Italian hospitals. A longitudinal study was conducted in two Italian cities (March 2018 to September 2020) enrolling 137 patients aged ≥65 years with CPE intestinal colonisation at hospital discharge. CPE colonisation was evaluated after 4, 8 and 12 months. Competing risk analysis was used to explore the association between baseline characteristics and persistence at 4 months. For all isolates, carbapenemase typing and multilocus sequence typing were performed. Persistent isolates underwent whole-genome sequencing. Of 137 patients, 91% carried carbapenemase-producing Klebsiella pneumoniae (CP-KP) and 8.8% carried carbapenemase-producing Escherichia coli. Although a large number of patients were lost to follow-up owing to death or withdrawal, 28/65 patients (43.1%) remained colonised at Month 4; 16/42 (38.1%) and 5/28 (17.9%) were found colonised up to Months 8 and 12, respectively. Colonisation persistence was more frequent in patients with bacteraemia or complicated urinary tract infection while in hospital and in those staying in long-term care facilities (LTCFs). Clonal characteristics of CP-KP isolates did not appear to influence persistence. Isolates obtained from each persistent carrier were identical or highly related by SNP phylogenetic analysis. Identification of patients at higher risk of persistent intestinal carriage after hospital discharge can prompt control measures to limit the transmission of CPE in the community, especially in LTCF settings.
产碳青霉烯酶肠杆菌科(CPE)对全球公共健康构成严重威胁。老年人发生 CPE 定植/感染的风险增加。本研究旨在评估意大利出院老年患者 CPE 定植的持续性和持续定植菌株的基因型特征。在两个意大利城市(2018 年 3 月至 2020 年 9 月)开展了一项纵向研究,纳入 137 名年龄≥65 岁且出院时存在肠道 CPE 定植的患者。在出院后 4、8 和 12 个月评估 CPE 定植情况。采用竞争风险分析探讨基线特征与 4 个月时持续性的关联。对所有分离株进行碳青霉烯酶分型和多位点序列分型。对所有持续性分离株进行全基因组测序。137 例患者中,91%携带产碳青霉烯酶肺炎克雷伯菌(CP-KP),8.8%携带产碳青霉烯酶大肠埃希菌。尽管由于死亡或退出,大量患者失访,但 65 例患者中有 28 例(43.1%)在第 4 个月仍定植;42 例中有 16 例(38.1%)和 28 例中有 5 例(17.9%)分别在第 8 和 12 个月定植。住院期间合并菌血症或复杂尿路感染以及入住长期护理机构(LTCF)的患者,定植持续性更常见。CP-KP 分离株的克隆特征似乎不影响持续性。通过 SNP 系统发育分析,从每个持续性携带者获得的分离株均相同或高度相关。确定出院后肠道持续携带风险较高的患者,可促使采取控制措施限制社区中 CPE 的传播,尤其是在 LTCF 环境中。